{"id":"W3187389031","doi":"10.18553/jmcp.2021.21164","title":"Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision Nanosystems (Canada)","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Sanofi","keywords":"Pembrolizumab; Medicine; Oncology; Clinical trial; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008443036,0.0014471,0.001777088,0.001949626,0.0002549483,0.001647818,0.001575251,0.001111081,0.00559964],"category_scores_gemma":[0.01866837,0.0006939784,0.00531884,0.001472302,0.0006697637,0.001375884,0.001094813,0.001850166,0.0002925475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007399637,"about_ca_system_score_gemma":0.003021277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01010337,"about_ca_topic_score_gemma":0.00552646,"domain_scores_codex":[0.9957545,0.003263155,0.0001380471,0.0002394851,0.0002972042,0.0003076519],"domain_scores_gemma":[0.9898372,0.008279589,0.0008743245,0.000193807,0.0003680937,0.000447031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01512848,0.0007273864,0.01047554,0.00152119,0.004953813,0.000193854,0.00006030018,0.9298949,0.0005824544,0.00581069,0.001836765,0.02881456],"study_design_scores_gemma":[0.005996907,0.01411653,0.02704639,0.001006425,0.008690652,0.000622755,0.0002931473,0.9267877,0.001216802,0.009146882,0.00495436,0.0001215346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9363841,0.01695736,0.01804332,0.002734467,0.0002230042,0.002523319,0.008917553,0.000144494,0.01407245],"genre_scores_gemma":[0.9928921,0.001407717,0.002865756,0.0002552995,0.0000352499,0.0003918621,0.001474639,0.00001360335,0.0006636858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01010337,"threshold_uncertainty_score":0.05368835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03911643639606383,"score_gpt":0.355140616847161,"score_spread":0.3160241804510972,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}